The Institute for Biotechnology and Medicine Industry said Tuesday it has developed a safer and more convenient vaccine against human respiratory syncytial virus (RSV), which causes tens of millions of infections worldwide every year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Politics
President names Hsu Hsi-hsiang as new prosecutor-general
03/13/2026 10:46 PM -
Society
6 injured in 7-vehicle crash on National Freeway No. 2
03/13/2026 10:32 PM -
Business
February PMI hits 4-year high, but Middle East war casts shadows: Experts
03/13/2026 09:18 PM -
Sports
Uni-Lions star Chen Chieh-hsien out 4-6 weeks with fractured finger
03/13/2026 07:58 PM -
Politics
Cabinet 'confident' U.S. forced labor probe won't affect trade deal
03/13/2026 07:36 PM